Severe pulmonary hypertension in a patient with systemic lupus erythematosus and minimal lupus activity

Internal Medicine

Volumn 41, Issue 2, 2002, Pages 109-112

  Kawamura, Nobutoshi ^a   Tsutsui, Hiroyuki ^a   Fukuyama, Kae ^a   Hayashidani, Shunji ^a   Koike, George ^a   Egashira, Kensuke ^b   Yasunobu, A B E ^b   Yamamoto, Hidetaka ^b   Tsuneyoshi, Masazumi ^c   Takeshita, Akira ^c  

^a Department of Medicine and Bioregulatory Science ^*

^b KYUSHU UNIVERSITY   (Japan)

^c Graduate School of Medical Sciences   (Japan)

Author keywords

Antinuclear antibody; Corticosteroids; Epoprostenol; Prostacyclin; Pulmonary infarction

Indexed keywords

ANTINUCLEAR ANTIBODY; CALCIUM ANTAGONIST; CORTICOSTEROID; OXYGEN; PREDNISOLONE; PROSTACYCLIN; WARFARIN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEATH; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART INDEX; HEMATOLOGIC DISEASE; HUMAN; HYPOCOMPLEMENTEMIA; LUNG ARTERY PRESSURE; LUNG INFARCTION; PERICARDIAL EFFUSION; PULMONARY HYPERTENSION; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0036118939     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.109     Document Type: Article

References (11)

1. Pulmonary hypertension in systemic lupus erythematosus
2. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus
3. Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary and hematologic disease
4. Systemic lupus erythematosus and pulmonary vascular hypertension
5. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
6. Primary pulmonary hypertension: Improved long-term effects and survival with continuous intravenous epoprostenol infusion
7. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension
8. 2 followed by its oral analogue
9. Pulmonary hypertension in systemic lupus erythematosus: Clinical association and survival in 18 patients
10. Treatment of severe pulmonary hypertension decondary to connective tissue disease with continuous IV epoprostenol (prostacyclin)
11. Experience and reason